Jessica Mendoza
👤 SpeakerAppearances Over Time
Podcast Appearances
But the quanta flow had problems. Here's Chris again.
But the quanta flow had problems. Here's Chris again.
But the quanta flow had problems. Here's Chris again.
The maker of Quantiflow, Semler Scientific, said the device assesses risk for the disease. UnitedHealth told us that it tests for the disease during home visits to diagnose it early, and that it expected clinicians to use their judgment.
The maker of Quantiflow, Semler Scientific, said the device assesses risk for the disease. UnitedHealth told us that it tests for the disease during home visits to diagnose it early, and that it expected clinicians to use their judgment.
The maker of Quantiflow, Semler Scientific, said the device assesses risk for the disease. UnitedHealth told us that it tests for the disease during home visits to diagnose it early, and that it expected clinicians to use their judgment.
According to the journal's reporting, those peripheral artery disease diagnoses led to nearly $1.4 billion in additional payments to UnitedHealth between 2019 and 2021. Semler Scientific was also under investigation by the Justice Department for potential fraud. The company announced in May it had reached a tentative agreement to settle the case for nearly $30 million.
According to the journal's reporting, those peripheral artery disease diagnoses led to nearly $1.4 billion in additional payments to UnitedHealth between 2019 and 2021. Semler Scientific was also under investigation by the Justice Department for potential fraud. The company announced in May it had reached a tentative agreement to settle the case for nearly $30 million.
According to the journal's reporting, those peripheral artery disease diagnoses led to nearly $1.4 billion in additional payments to UnitedHealth between 2019 and 2021. Semler Scientific was also under investigation by the Justice Department for potential fraud. The company announced in May it had reached a tentative agreement to settle the case for nearly $30 million.
The company did not respond to requests for comment about the investigation. Those questionable diagnoses weren't just for rare diseases like diabetic cataracts or peripheral artery disease. They were also for HIV, the virus that causes AIDS. During a four-year period, thousands of Medicare Advantage recipients had diagnoses of HIV added to their records by their insurance companies.
The company did not respond to requests for comment about the investigation. Those questionable diagnoses weren't just for rare diseases like diabetic cataracts or peripheral artery disease. They were also for HIV, the virus that causes AIDS. During a four-year period, thousands of Medicare Advantage recipients had diagnoses of HIV added to their records by their insurance companies.
The company did not respond to requests for comment about the investigation. Those questionable diagnoses weren't just for rare diseases like diabetic cataracts or peripheral artery disease. They were also for HIV, the virus that causes AIDS. During a four-year period, thousands of Medicare Advantage recipients had diagnoses of HIV added to their records by their insurance companies.
For each of these diagnoses, insurers received a payment of about $3,000 a year. But when Chris looked into patients' follow-up care, many of them weren't getting it.
For each of these diagnoses, insurers received a payment of about $3,000 a year. But when Chris looked into patients' follow-up care, many of them weren't getting it.
For each of these diagnoses, insurers received a payment of about $3,000 a year. But when Chris looked into patients' follow-up care, many of them weren't getting it.
Right, because the point of being diagnosed is so that you can get treatment.
Right, because the point of being diagnosed is so that you can get treatment.
Right, because the point of being diagnosed is so that you can get treatment.
Chris says that because of the way this diagnosis is added to a patient's records, some people may not even know about it. Among the UnitedHealth patients, according to Medicare data, hardly anyone given an HIV diagnosis in that period had started antiretroviral treatment in the following years.
Chris says that because of the way this diagnosis is added to a patient's records, some people may not even know about it. Among the UnitedHealth patients, according to Medicare data, hardly anyone given an HIV diagnosis in that period had started antiretroviral treatment in the following years.